scispace - formally typeset
A

Anucha Apisarnthanarak

Researcher at Thammasat University Hospital

Publications -  177
Citations -  3794

Anucha Apisarnthanarak is an academic researcher from Thammasat University Hospital. The author has contributed to research in topics: Health care & Acinetobacter baumannii. The author has an hindex of 31, co-authored 177 publications receiving 3173 citations.

Papers
More filters
Journal ArticleDOI

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

Victor D. Rosenthal, +825 more
TL;DR: The results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe were reported in this paper.
Journal ArticleDOI

Molecular Characterization and Epidemiology of Extended-Spectrum- β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic

TL;DR: Molecular detection and characterization of ESBL-related bla genes and pulsed-field gel electrophoresis analysis demonstrated that there was no major clonal relationship among these ESBL producers and CTX-M ESBL is highly endemic in the country.
Journal ArticleDOI

Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis

TL;DR: Combination therapy of colistin with sulbactam demonstrates superiority in terms of microbiological cure with a safety profile similar to that ofcolistin monotherapy, and support the use of this combination as a treatment for MDR- and XDR-AB infections.
Journal ArticleDOI

The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand☆

TL;DR: A novel CTX-M type of extended-spectrum beta-lactamase (ESBL) among 7 patients who had infection with ESBL-producing Escherichia coli or Klebsiella pneumoniae at a university hospital in Thailand showed reduced susceptibility to ceftazidime.
Journal ArticleDOI

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)

TL;DR: A surveillance program is recommended to monitor outcomes and adherence to evidence-based central line insertion and maintenance practices (compliance rate) and identify quality improvement opportunities and strategically targeting interventions for the reduction of CLABSI.